ONWARD Medical licenses CEA's WIMAGINE BCI for its ARC-BCI System, aiming to restore movement after paralysis.

ONWARD Medical has secured an exclusive license from CEA to develop the WIMAGINE Brain-Computer Interface (BCI) for its ARC-BCI System, aimed at restoring thought-driven movement after paralysis. This partnership positions ONWARD to be the first to market with such technology, which has shown early clinical promise. The deal includes a $1.1 million upfront payment and future royalties, enhancing ONWARD's innovation capabilities in spinal cord therapies.

October 15, 2024
4 Articles